akf.jpg
Christina Mahady, P.E., Leading Healthcare Engineer, Joins AKF
February 25, 2020 16:04 ET | AKF Group
NEW YORK, Feb. 25, 2020 (GLOBE NEWSWIRE) -- AKF, a global leader in engineering, technology, design, consulting, and commissioning, is pleased to announce that leading healthcare engineering expert,...
IBA DÉCLARATION INTE
IBA DÉCLARATION INTERMÉDIAIRE - TROISIÈME TRIMESTRE 2019
November 14, 2019 00:30 ET | IBA SA
Louvain-la-Neuve, Belgique, le 14 novembre 2019 - IBA (Ion Beam Applications S.A., EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie...
Iba Business Update
Iba Business Update – Third Quarter 2019
November 14, 2019 00:30 ET | IBA SA
Louvain-la-Neuve, Belgium, 14 November, 2019 - IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update...
IBA annonce ses résu
IBA annonce ses résultats du premier semestre 2019
August 22, 2019 01:00 ET | IBA SA
Hausse des revenus du groupe à hauteur de 13,8% pour atteindre EUR 102,8 millions, avec des revenus supérieurs attendus au second semestre 2019Position de leader confirmée sur le marché, tous secteurs...
IBA Reports Half Yea
IBA Reports Half Year Results for 2019
August 22, 2019 01:00 ET | IBA SA
Group revenue up 13.8% to EUR 102.8 million, with higher revenues expected over H2 2019Market leadership confirmed in all business lines and major geographiesTwo Proteus®ONE solutions sold in Italy...
IBA signe un contrat
IBA signe un contrat pour installer un centre de protonthérapie en Italie
May 28, 2019 01:00 ET | IBA SA
Un contrat Proteus®ONE* d’une valeur entre EUR 35 et 40 millions pour IBA Louvain-la-Neuve, Belgique, le 28 mai 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de...
IBA signs contract t
IBA signs contract to install proton therapy center in Italy
May 28, 2019 01:00 ET | IBA SA
Proteus®ONE contract worth between EUR 35 and 40 million to IBA Louvain-La-Neuve, Belgium, 28 May 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy...
IBA BUSINESS UPDATE
IBA BUSINESS UPDATE – FIRST QUARTER 2019
May 08, 2019 01:00 ET | IBA SA
Louvain-La-Neuve, Belgium, 8 May 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business...
IBA Déclaration Inte
IBA Déclaration Intermédiaire – Premier Trimestre 2019
May 08, 2019 01:00 ET | IBA SA
Louvain-la-Neuve, Belgique, le 8 mai 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie aujourd’hui une revue...
IBA Selected to Inst
IBA Selected to Install Five-room Proton Therapy System in Shenzhen, China
March 29, 2019 02:30 ET | IBA SA
IBA Selected to Install Five-room Proton Therapy System in Shenzhen, China Final contract negotiations for the public tender will start in the coming weeks Louvain-la-Neuve, Belgium, 29 March, 2019...